HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endotoxin inhibits apoptosis but induces primary necrosis in neutrophils.

Abstract
Lipopolysaccharide (LPS) is known to prolong the functional lifespan of neutrophils at a site of infection by preventing apoptosis through inhibitor of apoptosis proteins (IAPs). We hypothesized that the increased neutrophil lifespan ultimately leads to a larger fraction of cells undergoing uncontrolled, primary necrosis. Diluted venous whole blood was incubated with increasing concentrations of LPS for up to 36 hr. The percentages of apoptotic, necrotic and viable neutrophils were assessed using the Annexin V/propidium iodide flow cytometric assay. LPS led to a reduction of neutrophil apoptosis and increased the number of viable cells at 12, 24, and 36 hr of incubation. At the same time intervals, there was a significant increase in the percentage of cells undergoing primary necrosis for all concentrations of LPS (e.g., 10 ng/ml LPS at 24 h produced a mean increase from 9.6% in controls to 30.6%, p < 0.001). This increase in direct neutrophil necrosis following LPS activation may amplify local proinflammatory effects through less well controlled release of neutrophil contents into surrounding tissue.
AuthorsMatthias Turina, Frederick N Miller, Patrick P McHugh, William G Cheadle, Hiram C Polk Jr
JournalInflammation (Inflammation) Vol. 29 Issue 1 Pg. 55-63 (Feb 2005) ISSN: 0360-3997 [Print] United States
PMID16502347 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Annexin A5
  • Lipopolysaccharides
Topics
  • Annexin A5 (metabolism)
  • Apoptosis (drug effects)
  • Cell Survival (drug effects)
  • Dose-Response Relationship, Drug
  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • Lipopolysaccharides (pharmacology)
  • Necrosis (chemically induced)
  • Neutrophils (pathology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: